InvestorsHub Logo

TxTrader76

07/15/20 10:53 PM

#52620 RE: Learjetter #52618

Im kinda curious as how a shell company, as you describe it, made it to a xenograph study with a cancer drug at some fairly prestigious research facilities?

Or...

How a Shell company has had numerous medical journals write about there drug developement and work with viruses?

Or....

How a Shell company was capable of coming up with years of RNA, Main Protease, or Topoisomerase II data to support a patent and FDA Fast Track designation?

Or....

How a Shell company could obtain rights to, not just one but 4, generic cancer drugs?

It seems to me this is 3 very capable doctors who need funding to finish years of hard work and to bring this to fruition.








Helter Skelter

07/16/20 1:05 AM

#52637 RE: Learjetter #52618

Margins are outstanding.

Gross Profit $7,219 / $11,102 Revenues = 65%. Outstanding margins. Look at the growth in Revenues year over year (YoY). Outstanding. What percent is that? $206 to $11,102 QoQ...over 50x revenues Q1-2020 over Q1-2019...what is the percent? what is the 'hang up'...? Smart, huh? Grow revenues to fund operations, get rid of debt (and interest), cut all expenses, clean everything up...for what? Not to go out of business.

Our market cap is approx $2.7m. We think we have a/multiple drug(s) IP and wholesale that should value SBFM 10x (10¢s at least) to 100x (1$) to 1,000x (10$)...I'd love to be a part of the "FUNDING FORCE" that may bring this(these) drug(s) to the people of the planet...if not...and it only hits 7¢s before "the force" shuts it down...then so be it, lol, try to help "push it through", "break on through to the other side, break on through, break on through"...

Sometimes the cure has a hard time...clearing all the hurdles. Etoposide was/is pretty good. Right?

The image below was highlighting the "Office" while the point here, not going to re-image the Statement of Operations, is that the gross margins are EXCELLENT not "pretty pathetic" as...one might say, lol...

65% gross margins is awesome. Bezos would kill for those margins. And a lot less, lol...ugh...

It cost us $3,883 and we sell it for $11,102.



Frankly, I don't base my buys and sells on some factless chat room messages...

Its beyond irrelevant if you ask me.

Waste of time, money, and energy. Please, explain the saturated market to me...Margins are probably pathetic, being a saturated market.

Certainly don't need a public traded company to sell generic multivitams on amazon. I'm still pretty sure its a knock off of nutri pharma products. Everything else sbfm sell on amazon is.

https://www.inovpharma.com/supplements

Think they are on pace for like 20k a year....which happens to be their only income, ever!

Real or not, who cares. They never promoted its design or creation, just magically selling it. No updates, zero. Essential 9 does zero for shareholders. Probably barely stays afloat. Paying amazon, shippers, nutri. Guessing it slowly dies off.

Lol, you're "guessing"...means what?